Refine Search
(9)
(27)
(47)
(63)

Encephalitis - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Encephalitis - Pipeline Review, H2 2019’, provides an overview of the Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Encephalitis, comple...

Sedation - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sedation - Pipeline Review, H2 2019’, provides an overview of the Sedation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sedation, complete with anal...

Complex Regional Pain Syndrome - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Complex Regional Pain Syndrome - Pipeline Review, H2 2019’, provides an overview of the Complex Regional Pain Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Tourette Syndrome - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tourette Syndrome - Pipeline Review, H2 2019’, provides an overview of the Tourette Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tourette S...

Restless Legs Syndrome - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Restless Legs Syndrome - Pipeline Review, H2 2019’, provides an overview of the Restless Legs Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Obsessive-Compulsive Disorder - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Obsessive-Compulsive Disorder - Pipeline Review, H2 2019’, provides an overview of the Obsessive-Compulsive Disorder pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Fatigue - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fatigue - Pipeline Review, H2 2019’, provides an overview of the Fatigue pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fatigue, complete with analysi...

Hyperalgesia - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperalgesia - Pipeline Review, H2 2019’, provides an overview of the Hyperalgesia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperalgesia, comple...

Cluster Headache Syndrome - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cluster Headache Syndrome - Pipeline Review, H2 2019’, provides an overview of the Cluster Headache Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Depression - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2019’, provides an overview of the Depression pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Depression, complete wit...

Mild Cognitive Impairment - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2019’, provides an overview of the Mild Cognitive Impairment pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Epilepsy - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2019’, provides an overview of the Epilepsy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with anal...

Alzheimer's Disease - Pipeline Review, H1 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2019’, provides an overview of the Alzheimer's Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Nicotine Addiction - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nicotine Addiction - Pipeline Review, H1 2019’, provides an overview of the Nicotine Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nicotine...

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019’, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape.

The report provides comprehensive info...

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019’, provides an overview of the Spinal Muscular Atrophy (SMA) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Drug Addiction - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Drug Addiction - Pipeline Review, H1 2019’, provides an overview of the Drug Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Drug Addiction, ...

Autism - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Autism - Pipeline Review, H1 2019’, provides an overview of the Autism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Autism, complete with analysis b...

Traumatic Brain Injury - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Traumatic Brain Injury - Pipeline Review, H1 2019’, provides an overview of the Traumatic Brain Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Post-Operative Pain - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H1 2019’, provides an overview of the Post-Operative Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Post-O...

Fibromyalgia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fibromyalgia - Pipeline Review, H1 2019’, provides an overview of the Fibromyalgia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fibromyalgia, comple...

Alcohol Addiction - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alcohol Addiction - Pipeline Review, H1 2019’, provides an overview of the Alcohol Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Alcohol Ad...

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2019’, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) pipeline landscape.

The report provides ...

Batten Disease - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Batten Disease - Pipeline Review, H1 2019’, provides an overview of the Batten Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Batten Disease, ...

Encephalomyelitis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Encephalomyelitis - Pipeline Review, H1 2019’, provides an overview of the Encephalomyelitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Encephalom...

Dementia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dementia - Pipeline Review, H1 2019’, provides an overview of the Dementia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dementia, complete with anal...

Trigeminal Neuralgia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Trigeminal Neuralgia - Pipeline Review, H1 2019’, provides an overview of the Trigeminal Neuralgia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Trig...

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2019’, provides an overview of the Post-Traumatic Stress Disorder (PTSD) pipeline landscape.

The report provides comprehensive information on the thera...

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

The report provide...

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Complex Regional Pain Syndrome - Pipeline Review, H1 2019’, provides an overview of the Complex Regional Pain Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Schizophrenia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H2 2018’, provides an overview of the Schizophrenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Schizophrenia, com...

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2018’, provides an overview of the Amyotrophic Lateral Sclerosis pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Anesthetic Effect - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anesthetic Effect - Pipeline Review, H2 2018’, provides an overview of the Anesthetic Effect pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anesthetic...

Migraine - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Migraine - Pipeline Review, H2 2018’, provides an overview of the Migraine pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Migraine, complete with anal...

Cancer Pain - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cancer Pain - Pipeline Review, H2 2018’, provides an overview of the Cancer Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cancer Pain, complete ...

Insomnia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Insomnia - Pipeline Review, H2 2018’, provides an overview of the Insomnia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Insomnia, complete with anal...

Narcolepsy - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Narcolepsy - Pipeline Review, H2 2018’, provides an overview of the Narcolepsy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Narcolepsy, complete wit...

Spinal Cord Injury - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Spinal Cord Injury - Pipeline Review, H2 2018’, provides an overview of the Spinal Cord Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Spinal C...

Guillain-Barre Syndrome - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Guillain-Barre Syndrome - Pipeline Review, H2 2018’, provides an overview of the Guillain-Barre Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Low Back Pain - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Low Back Pain - Pipeline Review, H2 2018’, provides an overview of the Low Back Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Low Back Pain, com...

Binge Eating Disorder - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Binge Eating Disorder - Pipeline Review, H2 2018’, provides an overview of the Binge Eating Disorder pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bi...

Rett Syndrome - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rett Syndrome - Pipeline Review, H2 2018’, provides an overview of the Rett Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rett Syndrome, com...

Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2018’, provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome) pipeline landscape.

The report provides comprehensive in...

Friedreich Ataxia - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Friedreich Ataxia - Pipeline Review, H2 2018’, provides an overview of the Friedreich Ataxia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Friedreich...

Dyskinesia - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dyskinesia - Pipeline Review, H2 2018’, provides an overview of the Dyskinesia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dyskinesia, complete wit...

Opium (Opioid) Addiction - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Opium (Opioid) Addiction - Pipeline Review, H2 2018’, provides an overview of the Opium (Opioid) Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2018’, provides an overview of the Neuromyelitis Optica (Devic’s Syndrome) pipeline landscape.

The report provides comprehensive information on the t...

Chronic Traumatic Encephalopathy (CTE) - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Traumatic Encephalopathy (CTE) - Pipeline Review, H2 2018’, provides an overview of the Chronic Traumatic Encephalopathy (CTE) pipeline landscape.

The report provides comprehensive information on the the...

Visceral Pain - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Visceral Pain - Pipeline Review, H2 2018’, provides an overview of the Visceral Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Visceral Pain, com...

Parkinson's Disease - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2018’, provides an overview of the Parkinson's Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for...

Multiple Sclerosis - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2018’, provides an overview of the Multiple Sclerosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Multiple...

Neuropathic Pain - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2018’, provides an overview of the Neuropathic Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Neuropathic ...

Huntington Disease - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Huntington Disease - Pipeline Review, H1 2018’, provides an overview of the Huntington Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Huntingt...

Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2018’, provides an overview of the Globoid Cell Leukodystrophy (Krabbe Disease) pipeline landscape.

The report provides comprehensive informatio...

Dental Pain - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dental Pain - Pipeline Review, H1 2018’, provides an overview of the Dental Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dental Pain, complete ...

Canavan Disease - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Canavan Disease - Pipeline Review, H1 2018’, provides an overview of the Canavan Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Canavan Diseas...

Encephalopathy - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Encephalopathy - Pipeline Review, H1 2018’, provides an overview of the Encephalopathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Encephalopathy, ...

Progressive Supranuclear Palsy - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Progressive Supranuclear Palsy - Pipeline Review, H1 2018’, provides an overview of the Progressive Supranuclear Palsy pipeline landscape.

The report provides comprehensive information on the therapeutics unde...

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2018’, provides an overview of the Metachromatic Leukodystrophy (MLD) pipeline landscape.

The report provides comprehensive information on the therapeutic...

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H1 2018’, provides an overview of the Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneratio...

Cerebral Palsy - Pipeline Review, H1 2018

  • $2,000
  • January 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Pipeline Review, H1 2018, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape.

Cerebral palsy is a...

Smoking Addiction - Pipeline Review, H2 2017

  • $2,000
  • December 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Smoking Addiction - Pipeline Review, H2 2017’, provides an overview of the Smoking Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Smoking Ad...

Osteoarthritis Pain - Pipeline Review, H2 2017

  • $2,000
  • October 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H2 2017’, provides an overview of the Osteoarthritis Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteoa...

Brain Ischemia - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Brain Ischemia - Pipeline Review, H1 2017’, provides an overview of the Brain Ischemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Brain Ischemia, ...

Progressive Relapsing Multiple Sclerosis (PRMS) - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Progressive Relapsing Multiple Sclerosis (PRMS) - Pipeline Review, H2 2016’, provides an overview of the Progressive Relapsing Multiple Sclerosis (PRMS) pipeline landscape.

The report provides comprehensive info...

Infantile Spasm (West Syndrome) - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Infantile Spasm (West Syndrome) - Pipeline Review, H2 2016’, provides an overview of the Infantile Spasm (West Syndrome) pipeline landscape.

The report provides comprehensive information on the therapeutics unde...

Lennox-Gastaut Syndrome - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lennox-Gastaut Syndrome - Pipeline Review, H2 2016’, provides an overview of the Lennox-Gastaut Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Essential Tremor - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Essential Tremor - Pipeline Review, H2 2016’, provides an overview of the Essential Tremor pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Essential Tr...

Brain Hemorrhage - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Brain Hemorrhage - Pipeline Review, H2 2016’, provides an overview of the Brain Hemorrhage pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Brain Hemorr...

Brain Edema - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Brain Edema - Pipeline Review, H2 2016’, provides an overview of the Brain Edema pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Brain Edema, complete ...

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016’, provides an overview of the Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) pipeline landscape.

The report provides comp...

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2016’, provides an overview of the Bipolar Disorder (Manic Depression) pipeline landscape.

The report provides comprehensive information on the therapeut...

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016’, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS) pipeline landscape.

The report provides comprehensive informat...

Major Depressive Disorder - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Major Depressive Disorder - Pipeline Review, H2 2016’, provides an overview of the Major Depressive Disorder pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Dystonia - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dystonia - Pipeline Review, H2 2016’, provides an overview of the Dystonia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dystonia, complete with anal...

Peripheral Neuropathic Pain - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peripheral Neuropathic Pain - Pipeline Review, H2 2016’, provides an overview of the Peripheral Neuropathic Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Psychosis - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Psychosis - Pipeline Review, H2 2016’, provides an overview of the Psychosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Psychosis, complete with a...

Treatment Resistant Depression - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Treatment Resistant Depression - Pipeline Review, H2 2016’, provides an overview of the Treatment Resistant Depression pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Cognitive Impairment - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cogn...

Postherpetic Neuralgia - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H2 2016’, provides an overview of the Postherpetic Neuralgia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Chronic Pain - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H2 2016’, provides an overview of the Chronic Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chronic Pain, comple...

Lewy body Dementia - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lewy body Dementia - Pipeline Review, H2 2016’, provides an overview of the Lewy body Dementia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Lewy bod...

Acute Pain - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Pain - Pipeline Review, H2 2016’, provides an overview of the Acute Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Acute Pain, complete wit...

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016’, provides an overview of the Primary Progressive Multiple Sclerosis (PPMS) pipeline landscape.

The report provides comprehensive informat...

Ocular Pain - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ocular Pain - Pipeline Review, H2 2016’, provides an overview of the Ocular Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ocular Pain, complete ...

Anxiety Disorders - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H2 2016’, provides an overview of the Anxiety Disorders pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anxiety Di...

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016’, provides an overview of the Secondary Progressive Multiple Sclerosis (SPMS) pipeline landscape.

The report provides comprehensive info...

Status Epilepticus - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Status Epilepticus - Pipeline Review, H2 2016’, provides an overview of the Status Epilepticus pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Status E...

Nerve Injury - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nerve Injury - Pipeline Review, H2 2016’, provides an overview of the Nerve Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nerve Injury, comple...

Seizures - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Seizures - Pipeline Review, H2 2016’, provides an overview of the Seizures pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Seizures, complete with anal...

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2016’, provides an overview of the Peripheral Neuropathy (Sensory Neuropathy) pipeline landscape.

The report provides comprehensive information on...

Diabetic Neuropathic Pain - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H2 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...